Compounds > ah 6809
Page last updated: 2024-09-03

ah 6809 and fluprostenol

ah 6809 has been researched along with fluprostenol in 3 studies

Compound Research Comparison

Studies
(ah 6809)		Trials
(ah 6809)		Recent Studies (post-2010)
(ah 6809)		Studies
(fluprostenol)		Trials
(fluprostenol)		Recent Studies (post-2010) (fluprostenol)
16314998116

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, M; Kiriyama, M; Kobayashi, T; Narumiya, S; Sugimoto, Y; Ushikubi, F1
Abramovitz, M; Adam, M; Belley, M; Boie, Y; Carrière, M; Denis, D; Dufresne, C; Gallant, M; Gareau, Y; Godbout, C; Juteau, H; Labelle, M; Lamontagne, S; Metters, KM; Ouimet, N; Rochette, C; Ruel, R; Sawyer, N; Tremblay, NM1
Brink, C; de Montpreville, V; Norel, X; Walch, L1

Other Studies

3 other study(ies) available for ah 6809 and fluprostenol

ArticleYear
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    British journal of pharmacology, 1997, Volume: 122, Issue:2

    Topics: Animals; CHO Cells; Cricetinae; Ligands; Mice; Prostaglandins; Receptors, Prostaglandin; Transfection

1997
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.
    Biochimica et biophysica acta, 2000, Jan-17, Volume: 1483, Issue:2

    Topics: Binding, Competitive; Cell Line; Cell Membrane; Humans; Ligands; Prostaglandins; Radioligand Assay; Receptors, Prostaglandin; Recombinant Proteins

2000
Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    British journal of pharmacology, 2001, Volume: 134, Issue:8

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Carbazoles; Culture Techniques; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Iloprost; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Antagonists; Prostaglandins F, Synthetic; Pulmonary Veins; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Thromboxane; Sulfonamides; Vasoconstriction; Xanthenes; Xanthones

2001